REGAINE® for women

REGAINE® for Women solution contains minoxidil, the only clinically proven OTC medicinal treatment for hereditary hair loss.1,2

Single pack RRP £25.52

REGAINE® for Women Regular Strength1

Ingredient:

  • 2% minoxidil
  • Noticeable hair growth may be visible after 16 weeks
  • 3 out of 5 women reported hair re-growth after 32 weeks

Clinical trials have shown that REGAINE® for Women solution helps stop further hair loss in 4 out 5 cases, and can regrow some hair in 3 out of 5 women in 32 weeks

Through its active ingredient minoxidil, REGAINE® for Women works by increasing the supply of blood and nutrients to your hair follicles, helping to strengthen the existing hairs and encouraging them to grow. Over time, this process can produce thicker, more visible hair.

The best way for patients to use REGAINE® Solution for Women

  • Make sure the hair and scalp are completely dry before applying the solution
  • Apply a 1ml dose to the total affected areas twice daily using the best applicator for you
  • The solution should be massaged lightly into the scalp after application
  • Always wash the hands thoroughly after applying the solution

There are 3 different applicators a patient can choose from when applying the solution:

Option 1: Pump spray applicator

  • works best for applying the solution to large areas of the scalp
  • a total of 6 sprays will deliver the 1ml dose of Minoxidil which is required

Option 2: Extended spray-tip applicator

  • works best for applying the solution to small areas of the scalp, or under hair
  • a total of 6 sprays will deliver the 1ml dose of Minoxidil which is required

Option 3: Rub-on applicator

  • works best for applying the solution to small areas of the scalp
  • hold the bottle upright and squeeze the bottle to fill the upper chamber to the black line - the chamber contains one full dose of Minoxidil which is required

If the patient sees no improvement in their hair growth after one year of use, they should discontinue use.

  • REGAINE® for Women Regular Strength Summary of Product Characteristics.
  • Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal of the German Society of Dermatology 2011;9 (Suppl 6):S1–57.
  • NHS Choices. Live well. Women and Hair Loss.

    http://www.nhs.uk/livewell/hairloss/pages/womenandhairloss.aspx [Accessed September2013]